Brief: Jacobio Pharmaceuticals Announces Collaboration With Merck
13/10/2022 02:40
Oct 13 (Reuters) - Jacobio Pharmaceuticals Group Co Ltd
1167.HK :
* COLLABORATION WITH MERCK ON COMBINATION THERAPY OF
JAB-21822 AND
CETUXIMAB
Further company coverage: 1167.HK
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Jacobio Pharmaceuticals
See all newsBrief: Jacobio Pharmaceuticals Appoints Xiaojie Wang As Vice Chairperson
China's Jacobio Pharmaceuticals H1 revenue jumps on licensing boost
Brief: Jacobio Pharmaceuticals Group Posts H1 Net Income Attributable RMB 600.6 Million
Brief: Jacobio Pharmaceuticals Expects HY Net Profit Of Not Less Than RMB600 Million
HK-listed Jacobio Pharmaceuticals climbs on share buyback plan